Back
Enliven Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
ELVN
Enliven Therapeutics, Inc.
Last Price:
$16.27
Seasonality Move:
-8.68%
7 Day Trial
ALL ACCESS PASS
$
7
Enliven Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Enliven Therapeutics, Inc. has on average historically risen by 4.5% based on the past 5 years of stock performance.
-
Enliven Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Enliven Therapeutics, Inc. Stock Undervalued?The current Enliven Therapeutics, Inc. [ELVN] share price is $16.30. The Score for ELVN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
ELVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Enliven Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Enliven Therapeutics, Inc. has on average historically risen by 4.5% based on the past 5 years of stock performance.
Enliven Therapeutics, Inc. Stock Rating
Sell
21
Enliven Therapeutics, Inc. (ELVN)
is a Sell
Is Enliven Therapeutics, Inc. overpriced?
-
Enliven Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Enliven Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
enliventherapeutics.com
52-Week Data
52-Week High:
25.37
52-Week Low:
13.30
Prediction Charts
Market Cap:
967.4M
Price in USD:
16.30
Volume:
510.9K
Beta:
0.92
Technical Analysis
SMA50:
20.07
SMA100:
19.94
SMA200:
19.82
52-Wk Change:
-28.23%
Stock Predictions
-
Is Enliven Therapeutics, Inc. stock public?Yes, Enliven Therapeutics, Inc. is a publicly traded company.
-
What is the Enliven Therapeutics, Inc. stock quote today?The Enliven Therapeutics, Inc. stock price is 16.30 USD today.
-
How to buy Enliven Therapeutics, Inc. stock online?You can buy Enliven Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-8 | 21.92 | 20.52 | 22.07 | 20.49 |
| Dec-9 | 20.41 | 19.49 | 20.41 | 17.31 |
| Dec-10 | 19.51 | 20.17 | 20.47 | 19.29 |
| Dec-11 | 19.99 | 18.77 | 20.20 | 18.14 |
| Dec-12 | 18.70 | 16.86 | 18.81 | 16.62 |
| Dec-15 | 17.18 | 17.17 | 17.44 | 16.77 |
| Dec-16 | 17.08 | 16.91 | 17.38 | 16.36 |
| Dec-17 | 16.95 | 16.02 | 17.58 | 15.71 |
| Dec-18 | 16.18 | 16.68 | 16.90 | 15.77 |
| Dec-19 | 16.71 | 16.87 | 17.15 | 16.61 |
| Dec-22 | 16.78 | 17.93 | 18.05 | 16.51 |
| Dec-23 | 17.84 | 16.53 | 17.88 | 16.48 |
| Dec-24 | 16.67 | 16.73 | 16.85 | 16.47 |
| Dec-26 | 16.71 | 16.30 | 16.71 | 15.88 |
Enliven Therapeutics, Inc. Earnings
Enliven Therapeutics, Inc. Earnings Report: Per Share Enliven Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Enliven Therapeutics, Inc. Forecast Revenue Growth
Enliven Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Enliven Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.32 per share.
* Enliven Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.